MPS Pharmaa Ltd Financial Ratios
531686 · Healthcare · Current price ₹1.99
P/E ratio
—
P/B ratio
53.3x
ROE
-83.3%
ROCE
-9.8%
Debt / Equity
—
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | — | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 53.3x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -83.3% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -9.8% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | — | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with MPS Pharmaa Ltd's latest numbers.
MPS Pharmaa Ltd profitability
MPS Pharmaa Ltd generates a return on equity of -83.3% and a return on capital employed of -9.8%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of n/a and a P/E of —, MPS Pharmaa Ltd is conservatively financed. Our overall business-quality score for the company is 2.5 / 10.
Understand the ratios
More on MPS Pharmaa Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.